| 0.95 Data as of 4:00pm ET |  +0.14 / +17.28%Today’s Change | 0.61 Today|||52-Week Range 1.85 | +3.26% Year-to-Date |
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Theeuwes Felix Chairman & Chief Scientific Officer |  Buy | 11/13/2012 | 46,600 | $1.01 | $47.1K | -5.00% |
Theeuwes Felix Chairman & Chief Scientific Officer | Buy | 11/13/2012 | 26,700 | $1.02 | $27.2K | -5.00% |
Yum Su Il Executive VP-Pharmaceutical Research & Development | Buy | 10/17/2012 | 31,076 | $0.78 | $24.2K | -41.72% |
Yum Su Il Executive VP-Pharmaceutical Research & Development | Buy | 10/17/2012 | 28,004 | $0.78 | $21.8K | -41.72% |
Theeuwes Felix Chairman & Chief Scientific Officer | Buy | 11/13/2012 | 16,100 | $1.00 | $16.1K | -5.00% |
Yum Su Il Executive VP-Pharmaceutical Research & Development | Buy | 10/17/2012 | 14,374 | $0.78 | $11.2K | -41.72% |
Saxe Jon S Director | Buy | 12/12/2012 | 9,700 | $0.91 | $8.8K | +7.34% |
Theeuwes Felix Chairman & Chief Scientific Officer | Buy | 11/13/2012 | 6,200 | $1.03 | $6.4K | -5.00% |
Saxe Jon S Director | Buy | 8/23/2012 | 5,000 | $1.00 | $5.0K | -5.00% |
Saxe Jon S Director | Buy | 8/28/2012 | 5,000 | $0.98 | $4.9K | -2.97% |
.
